Literature DB >> 15664727

p53: guardian AND suppressor of longevity?

Lawrence A Donehower1.   

Abstract

The p53 tumor suppressor gene enhances longevity by inhibiting cancer development. However, Van Heemst et al. in this issue show that polymorphisms in the p53 gene may affect longevity in unexpected ways. A meta-analysis indicates that individuals homozygous for the p53 codon 72 Pro allele instead of the more prevalent Arg allele have a modest increase in cancer incidence. This difference in cancer suspectibility is consistent with molecular studies showing that the p53 Pro polymorphic variant is a less robust anti-proliferative molecule than its Arg counterpart. The most surprising result was obtained in a prospective study of individuals age 85 or older. Despite having a 2.5-fold increased cancer incidence, the p53 codon 72 Pro/Pro individuals exhibited a significant 41% enhanced survival compared to codon 72 Arg/Pro and Arg/Arg individuals. These paradoxical findings suggest that p53 may enhance survival through most of our life span, but may actively suppress longevity during old age. The mechanisms for such duplicity remain unclear, but insights from p53 mutant mouse models may help to sort out the mystery.

Entities:  

Mesh:

Year:  2005        PMID: 15664727     DOI: 10.1016/j.exger.2004.10.007

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  16 in total

1.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

2.  Cancer and longevity--is there a trade-off? A study of cooccurrence in Danish twin pairs born 1900-1918.

Authors:  Kaare Christensen; Jacob K Pedersen; Jacob V B Hjelmborg; James W Vaupel; Tinna Stevnsner; Niels V Holm; Axel Skytthe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-03       Impact factor: 6.053

3.  Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.

Authors:  G Bougeard; S Baert-Desurmont; I Tournier; S Vasseur; C Martin; L Brugieres; A Chompret; B Bressac-de Paillerets; D Stoppa-Lyonnet; C Bonaiti-Pellie; T Frebourg
Journal:  J Med Genet       Date:  2005-10-28       Impact factor: 6.318

4.  TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.

Authors:  Ana Coelho; Augusto Nogueira; Sílvia Soares; Joana Assis; Deolinda Pereira; Isabel Bravo; Raquel Catarino; Rui Medeiros
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

5.  TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort.

Authors:  Helena S Thurow; Ricardo Haack; Fernando P Hartwig; Isabel O De Oliveira; Odir A Dellagostin; Denise P Gigante; Bernardo L Horta; Tiago Collares; Fabiana K Seixas
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

Review 6.  Gene polymorphisms, apoptotic capacity and cancer risk.

Authors:  Evgeny N Imyanitov
Journal:  Hum Genet       Date:  2009-02-12       Impact factor: 4.132

Review 7.  Ionizing radiation and aging: rejuvenating an old idea.

Authors:  Richard B Richardson
Journal:  Aging (Albany NY)       Date:  2009-11-17       Impact factor: 5.682

8.  It's all about balance: p53 and aging.

Authors:  Benoit Biteau; Heinrich Jasper
Journal:  Aging (Albany NY)       Date:  2009-11-13       Impact factor: 5.682

9.  p53 responsive elements in human retrotransposons.

Authors:  C R Harris; A Dewan; A Zupnick; R Normart; A Gabriel; C Prives; A J Levine; J Hoh
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

10.  JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines.

Authors:  Wanke Zhao; Yanhong Du; Wanting Tina Ho; Xueqi Fu; Zhizhuang Joe Zhao
Journal:  Exp Hematol Oncol       Date:  2012-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.